First-in-human phase I studies of YJ001 spray applied to local skin in healthy subjects and patients with diabetic neuropathic pain

Xiding Yanga Department of Pharmacy, The Second Xiangya Hospital of Central South University, Changsha, China;b Phase I Clinical Trial Center, The Second Xiangya Hospital of Central South University, Changsha, ChinaView further author information

Ronghua Zhua Department of Pharmacy, The Second Xiangya Hospital of Central South University, Changsha, China;b Phase I Clinical Trial Center, The Second Xiangya Hospital of Central South University, Changsha, ChinaView further author information

Jing Zhangc Zhejiang Yuejia Pharmaceuticals Co, Ltd, Zhejiang, ChinaView further author information

Zaihua Houc Zhejiang Yuejia Pharmaceuticals Co, Ltd, Zhejiang, ChinaView further author information

Lingfeng Yangd Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, China;b Phase I Clinical Trial Center, The Second Xiangya Hospital of Central South University, Changsha, ChinaView further author information

Xiao Fana Department of Pharmacy, The Second Xiangya Hospital of Central South University, Changsha, China;b Phase I Clinical Trial Center, The Second Xiangya Hospital of Central South University, Changsha, ChinaView further author information

Qiangyong Yana Department of Pharmacy, The Second Xiangya Hospital of Central South University, Changsha, China;b Phase I Clinical Trial Center, The Second Xiangya Hospital of Central South University, Changsha, ChinaView further author information

Jingjing Lia Department of Pharmacy, The Second Xiangya Hospital of Central South University, Changsha, ChinaView further author information

Zhiguang Zhoud Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, ChinaCorrespondence[email protected]
View further author information

Pingfei Fanga Department of Pharmacy, The Second Xiangya Hospital of Central South University, Changsha, China;b Phase I Clinical Trial Center, The Second Xiangya Hospital of Central South University, Changsha, ChinaCorrespondence[email protected]

https://orcid.org/0000-0001-9593-9739 View further author information

show all

Citations (0)

Keep up to date with the latest research on this topic with citation updates for this article.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

First-in-human phase I studies of YJ001 spray applied to local skin in healthy subjects and patients with diabetic neuropathic pain

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

First-in-human phase I studies of YJ001 spray applied to local skin in healthy subjects and patients with diabetic neuropathic pain

Citations (0)

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date